Chicago Graffiti

One challenge with new product development is a raft of agents coming through offers fresh promise for the future… but will they stand up under scrutiny?

Success often happens slowly, then suddenly there is a new development with a different approach or take on a target and off we go again, chasing the pot of gold at the end of a rainbow.

In today’s review we put a new batch of products through their paces to see what they offer, all bar one are now in phase 1 testing…

To continue reading our latest highlights on oncology new product development including commentary and analysis BSB subscribers can log-in or you can click to access the content.

This content is restricted to subscribers

Posted by